Try our Advanced Search for more refined results
- Law360
- Law360 UK
- Law360 Pulse
- Law360 Employment Authority
- Law360 Tax Authority
- Law360 Insurance Authority
- Law360 Real Estate Authority
- Law360 Healthcare Authority
- Law360 Bankruptcy Authority
- Products
- Lexis®
- Law360 In-Depth
- Law360 Podcasts
- Rankings
- Leaderboard Analytics
- Regional Powerhouses
- Law360's MVPs
- Women in Law Report
- Law360 400
- Diversity Snapshot
- Practice Groups of the Year
- Rising Stars
- Titans of the Plaintiffs Bar
- Sections
- Adv. Search & Platform Tools
- About all sections
- Browse all sections
- Banking
- Bankruptcy
- Class Action
- Competition
- Employment
- Energy
- Expert Analysis
- Insurance
- Intellectual Property
- Product Liability
- Securities
- Beta Tools
- Track docs
- Track attorneys
- Track judges
United States of America v. MALLINCKRODT ARD LLC
Case Number:
1:18-cv-11931
Court:
Nature of Suit:
Judge:
Firms
Companies
Government Agencies
- Commonwealth of Massachusetts
- State of Indiana
- State of Maryland
- State of Michigan
- State of Nevada
- State of Tennessee
- U.S. District Court for the District of Columbia
Sectors & Industries:
-
March 07, 2022
Mallinckrodt Inks $260M Deal Ending DOJ Medicaid Claims
Mallinckrodt ARD LLC has agreed to pay $260 million to resolve government allegations that it underpaid Medicaid rebates for its Acthar gel products and paid illegal kickbacks to induce Medicare patients to buy its drugs, the U.S. Department of Justice said Monday.
-
July 13, 2020
Mallinckrodt Aims To Nix Medicaid FCA Suit Over Acthar Gel
The government is wrongly conflating fraud with a regulatory disagreement, Mallinckrodt ARD LLC told a Massachusetts federal court Monday, urging a judge to toss False Claims Act claims centering on its pricey H.P. Acthar Gel drug, which treats infantile spasms and other conditions.
-
March 03, 2020
DOJ Says Mallinckrodt Bilked Medicaid As Drug Price Soared
Mallinckrodt ARD Inc. shortchanged Medicaid by hundreds of millions of dollars as the company hiked the price of its drug H.P. Acthar Gel, the U.S. Department of Justice alleged in a False Claims Act suit unsealed Tuesday in Massachusetts.